CN103585591A - Traditional Chinese medicine for treating gallstones - Google Patents
Traditional Chinese medicine for treating gallstones Download PDFInfo
- Publication number
- CN103585591A CN103585591A CN201310624777.0A CN201310624777A CN103585591A CN 103585591 A CN103585591 A CN 103585591A CN 201310624777 A CN201310624777 A CN 201310624777A CN 103585591 A CN103585591 A CN 103585591A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- herba
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine for treating gallstones. The traditional Chinese medicine is prepared from the following raw materials by weight: 10 to 25 parts of Chinese thorowax root, 10 to 20 parts of immature orange fruit, 15 to 30 parts of dried orange peel, 8 to 15 parts of small centipeda herb, 12 to 25 parts of raw rhubarb root and rhizome, 30 to 50 parts of desmodium, 30 to 50 parts of virgate wormwood herb, 12 to 20 parts of curcuma tuber, 12 to 25 parts of Sichuan chinaberry fruit and 5 to 10 parts of rhizoma corydalis. According to the invention, desmodium and virgate wormwood herb are used as main drugs, other adjuvant drugs are cooperatively used, the main drugs and the adjuvant drugs influence each other and produce synergistic effects, so the traditional Chinese medicine is capable of soothing the liver and the gallbladder, clearing heat, eliminating dampness, rectifying qi, harmonizing nutrient qi, relieving pain and dissipating binds, exerts a good treatment effect on patients with gallstones and has the advantages of safety, no side-effects, simple preparation and convenient administration.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of cholelithiasis.
Background technology
Cholelithiasis refers to the caused disease of the calculus occurring in gallbladder, is a kind of commonly encountered diseases.With age growth, sickness rate also raises gradually, and women is obviously more than male.Along with growth in the living standard, the change of dietary habit, the improvement of sanitary condition, the cholelithiasis of China be take gallbladder cholesterol calculus as main by take the bile pigment calculus of bile duct as main changing into gradually.The medicine for the treatment of cholelithiasis is a lot of at present, for example publication number is: CN102178889A, name is called the Chinese invention patent application that mono-kind of < < treats the Chinese medicine preparation > > of cholelithiasis, the invention provides a kind of Chinese medicine preparation for the treatment of cholelithiasis, it is to be made by following raw material of Chinese medicine: Medulla Tetrapanacis, Herba Taraxaci, Endothelium Corneum Gigeriae Galli, Poria, Semen Plantaginis, Radix Ranunculi Ternati, Stigma Maydis, Rhizoma Polygoni Cuspidati, Semen Abutili, Matrii Sulfas Exsiccatus, Fructus Forsythiae, Flos Lonicerae, Fructus Aurantii Immaturus, Pericarpium Citri Reticulatae Viride, Herba Lysimachiae, Concha Haliotidis, Radix Curcumae, Fructus Toosendan, Radix Pseudostellariae, Pollen Typhae, Oletum Trogopterori, Radix Glycyrrhizae, Herba Centipedae, Radix Scutellariae, Cortex Magnoliae Officinalis, Radix Isatidis, this Chinese medicine preparation has good clinical therapeutic efficacy to the Patients with Cholelithiasis in each stage, and the medication initial stage just can be obtained good therapeutic effect, can significantly improve the pain that cholelithiasis causes, abdominal distention, and constipation, the symptoms such as yellowish urine, effectively mediate cholelithiasis, calculus of bile duct.The outstanding effect of this Chinese medicine preparation is to have no side effect, and is difficult for the advantages such as recurrence and medical expense cheap.But the compatibility more complicated of this medicine.
Summary of the invention
The technical problem to be solved in the present invention is to provide the Chinese medicine of the treatment cholelithiasis that a kind of compatibility is comparatively simple, safe and reliable, therapeutic effect is good.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
The present invention treats the Chinese medicine of cholelithiasis, is to be made by the raw material of following weight proportioning:
Radix Bupleuri 10~25, Fructus Aurantii Immaturus 10~20, Pericarpium Citri Reticulatae 15~30, Herba Centipedae 8~15, Radix Et Rhizoma Rhei 12~25, Herba Lysimachiae 30~50, Herba Artemisiae Scopariae 30~50, Radix Curcumae 12~20, Fructus Toosendan 12~25, Rhizoma Corydalis 5~10.
The preferred weight proportioning of each raw material is:
Radix Bupleuri 15~20, Fructus Aurantii Immaturus 12~18, Pericarpium Citri Reticulatae 20~25, Herba Centipedae 10~13, Radix Et Rhizoma Rhei 18~22, Herba Lysimachiae 35~45, Herba Artemisiae Scopariae 35~45, Radix Curcumae 15~18, Fructus Toosendan 18~23, Rhizoma Corydalis 6~9.
The optimum weight proportioning of each raw material is:
Radix Bupleuri 18, Fructus Aurantii Immaturus 15, Pericarpium Citri Reticulatae 22, Herba Centipedae 12, Radix Et Rhizoma Rhei 20, Herba Lysimachiae 40, Herba Artemisiae Scopariae 40, Radix Curcumae 17, Fructus Toosendan 21, Rhizoma Corydalis 7.
The preparation method that the present invention treats the Chinese medicine of cholelithiasis is: take by weight ratio raw material Radix Bupleuri, Fructus Aurantii Immaturus, Pericarpium Citri Reticulatae, Herba Centipedae, Radix Et Rhizoma Rhei, Herba Lysimachiae, Herba Artemisiae Scopariae, Radix Curcumae, Fructus Toosendan, Rhizoma Corydalis, add the decocting of 8~12 times of raw material weights to boil, after water boils, slow fire boils 50~80 minutes, leach medicinal liquid, obtain.
The instructions of taking that the present invention treats the Chinese medicine of cholelithiasis is: oral, every day 2 times, each serving 300~400 grams.
It is principal agent that the Chinese medicine that the present invention treats cholelithiasis be take Herba Lysimachiae and Herba Artemisiae Scopariae, other accessory drugs of arranging in pairs or groups, they influence each other, synergism, thereby play good depressed liver-energy dispersing and function of gallbladder promoting, removing damp-heat, regulate the flow of vital energy and battalion, pain-relieving powder for treating mass-dissipating efficacy, Patients with Cholelithiasis is had to good therapeutic effect, and it has no side effect safely, preparation method is simple, and it is also convenient to take.
The specific embodiment
With embodiment, the invention will be further described below, but the present invention is not limited to these embodiment.
Umber described in following embodiment is weight portion.
Embodiment 1
Drug weight proportioning:
10 parts of Radix Bupleuri, 10 parts of Fructus Aurantii Immaturuss, 15 parts of Pericarpium Citri Reticulataes, 8 parts of Herba Centipedae, 12 parts of Radix Et Rhizoma Rhei, 30 parts of Herba Lysimachiaes, 30 parts of Herba Artemisiae Scopariaes, 12 parts of Radix Curcumaes, 12 parts of Fructus Toosendans, 5 parts of Rhizoma Corydalis.
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 8 times of raw material weights to boil, after water boils, slow fire boils 50 minutes, leaches medicinal liquid, obtains.
Embodiment 2
Drug weight proportioning:
25 parts of Radix Bupleuri, 20 parts of Fructus Aurantii Immaturuss, 30 parts of Pericarpium Citri Reticulataes, 15 parts of Herba Centipedae, 25 parts of Radix Et Rhizoma Rhei, 50 parts of Herba Lysimachiaes, 50 parts of Herba Artemisiae Scopariaes, 20 parts of Radix Curcumaes, 25 parts of Fructus Toosendans, 10 parts of Rhizoma Corydalis.
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 10 times of raw material weights to boil, after water boils, slow fire boils 65 minutes, leaches medicinal liquid, obtains.
Embodiment 3
Drug weight proportioning:
18 parts of Radix Bupleuri, 15 parts of Fructus Aurantii Immaturuss, 22 parts of Pericarpium Citri Reticulataes, 12 parts of Herba Centipedae, 20 parts of Radix Et Rhizoma Rhei, 40 parts of Herba Lysimachiaes, 40 parts of Herba Artemisiae Scopariaes, 17 parts of Radix Curcumaes, 21 parts of Fructus Toosendans, 7 parts of Rhizoma Corydalis.
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 12 times of raw material weights to boil, after water boils, slow fire boils 80 minutes, leaches medicinal liquid, obtains.
Experimental example:
Below example is further set forth the beneficial effect that the present invention treats the Chinese medicine of cholelithiasis by experiment.
1, experiment crowd:
Be divided into A, two experimental grouies of B:
A group: cholelithiasis female patient 100 examples; 30~45 years old age.
B group: cholelithiasis male patient's 86 examples; 45~60 years old age.
2, drug administration method:
Chinese medicine every day of the treatment cholelithiasis that the oral embodiment of the present invention 3 makes 2 times, each serving 400 grams, serve on 15 days.
3, efficacy evaluation:
(1) invalid: with take medicine before compare, without significant change.
(2) effective: effect is remarkable.
4, therapeutic effect:
Claims (3)
1. treat a Chinese medicine for cholelithiasis, it is characterized in that being made by the raw material of following weight proportioning:
Radix Bupleuri 10~25, Fructus Aurantii Immaturus 10~20, Pericarpium Citri Reticulatae 15~30, Herba Centipedae 8~15, Radix Et Rhizoma Rhei 12~25, Herba Lysimachiae 30~50, Herba Artemisiae Scopariae 30~50, Radix Curcumae 12~20, Fructus Toosendan 12~25, Rhizoma Corydalis 5~10.
2. the Chinese medicine for the treatment of cholelithiasis according to claim 1, is characterized in that the weight proportion of each raw material is:
Radix Bupleuri 15~20, Fructus Aurantii Immaturus 12~18, Pericarpium Citri Reticulatae 20~25, Herba Centipedae 10~13, Radix Et Rhizoma Rhei 18~22, Herba Lysimachiae 35~45, Herba Artemisiae Scopariae 35~45, Radix Curcumae 15~18, Fructus Toosendan 18~23, Rhizoma Corydalis 6~9.
3. the Chinese medicine for the treatment of cholelithiasis according to claim 2, is characterized in that the weight proportion of each raw material is:
Radix Bupleuri 18, Fructus Aurantii Immaturus 15, Pericarpium Citri Reticulatae 22, Herba Centipedae 12, Radix Et Rhizoma Rhei 20, Herba Lysimachiae 40, Herba Artemisiae Scopariae 40, Radix Curcumae 17, Fructus Toosendan 21, Rhizoma Corydalis 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310624777.0A CN103585591A (en) | 2013-11-28 | 2013-11-28 | Traditional Chinese medicine for treating gallstones |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310624777.0A CN103585591A (en) | 2013-11-28 | 2013-11-28 | Traditional Chinese medicine for treating gallstones |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103585591A true CN103585591A (en) | 2014-02-19 |
Family
ID=50076044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310624777.0A Pending CN103585591A (en) | 2013-11-28 | 2013-11-28 | Traditional Chinese medicine for treating gallstones |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103585591A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758423A (en) * | 2015-04-22 | 2015-07-08 | 李丽丽 | Traditional Chinese medicine prescription for treating gallstone |
CN104771637A (en) * | 2015-04-22 | 2015-07-15 | 李丽丽 | Cholagogic and lithagogue agent for treating gallstone and preparation method thereof |
CN104800755A (en) * | 2015-04-22 | 2015-07-29 | 李丽丽 | Medicament for treating gallstones and preparation method |
CN106420954A (en) * | 2016-11-29 | 2017-02-22 | 佘延英 | Traditional Chinese medicine for treating gallstone |
-
2013
- 2013-11-28 CN CN201310624777.0A patent/CN103585591A/en active Pending
Non-Patent Citations (1)
Title |
---|
百度百科: "胆结石中药方剂", 《HTTP://BAIKE.BAIDU.COM/VIEW/9070183.HTM》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758423A (en) * | 2015-04-22 | 2015-07-08 | 李丽丽 | Traditional Chinese medicine prescription for treating gallstone |
CN104771637A (en) * | 2015-04-22 | 2015-07-15 | 李丽丽 | Cholagogic and lithagogue agent for treating gallstone and preparation method thereof |
CN104800755A (en) * | 2015-04-22 | 2015-07-29 | 李丽丽 | Medicament for treating gallstones and preparation method |
CN106420954A (en) * | 2016-11-29 | 2017-02-22 | 佘延英 | Traditional Chinese medicine for treating gallstone |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101485836A (en) | Oral capsule for treating neck, waist and leg pain diseases and preparation method thereof | |
CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
CN101804189B (en) | Drug for treating primary dysmenorrhea | |
CN102114230A (en) | Medicament for treating psoriasis | |
CN101897879A (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
CN100381155C (en) | Medicine for treating mammary glands hyperplasia | |
CN102886036B (en) | Traditional Chinese medicine for treating syndrome of congealing cold with blood stasis type dysmenorrheal disease | |
CN103720981A (en) | Traditional Chinese medicine for treating dysentery | |
CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
CN104027514A (en) | Traditional Chinese medicine used for treating acute cholecystitis | |
CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
CN103705855A (en) | Traditional Chinese medicine for treating thyroiditis | |
CN1686227A (en) | Menstruation regulating powder | |
CN103893601B (en) | A kind of medicament for the treatment of mumps | |
CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
CN104383097A (en) | Traditional Chinese medicine for treating lupus erythematosus | |
CN103479815A (en) | Traditional Chinese medicine for treating urinary tract infection | |
CN103263516B (en) | Medicine for treating cholecystitis | |
CN102205101B (en) | Formula of Chinese medicine for treating functional uterine bleeding | |
CN102366591B (en) | Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method | |
CN102233063A (en) | Traditional Chinese medicine composition for treating toothache | |
CN103550507A (en) | Traditional Chinese medicine for treating leukemia | |
CN104510827A (en) | Traditional Chinese medicine for treating acne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140219 |